These results suggest that the basement membrane thickening and remodeled ECM composition in the BBB may be a pathological contribution to APOEε4-mediated AD pathology that may be mitigated by variants in FN1 or other ECM genes (Fig. 8). The gene discussed is MMRN1; the disease is Alzheimer disease.